X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
98
PharmaCompass offers a list of Tafamidis API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafamidis manufacturer or Tafamidis supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafamidis manufacturer or Tafamidis supplier.
PharmaCompass also assists you with knowing the Tafamidis API Price utilized in the formulation of products. Tafamidis API Price is not always fixed or binding as the Tafamidis Price is obtained through a variety of data sources. The Tafamidis Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tafamidis manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tafamidis, including repackagers and relabelers. The FDA regulates Tafamidis manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tafamidis API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tafamidis manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tafamidis supplier is an individual or a company that provides Tafamidis active pharmaceutical ingredient (API) or Tafamidis finished formulations upon request. The Tafamidis suppliers may include Tafamidis API manufacturers, exporters, distributors and traders.
click here to find a list of Tafamidis suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tafamidis DMF (Drug Master File) is a document detailing the whole manufacturing process of Tafamidis active pharmaceutical ingredient (API) in detail. Different forms of Tafamidis DMFs exist exist since differing nations have different regulations, such as Tafamidis USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tafamidis DMF submitted to regulatory agencies in the US is known as a USDMF. Tafamidis USDMF includes data on Tafamidis's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tafamidis USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tafamidis suppliers with USDMF on PharmaCompass.
A Tafamidis written confirmation (Tafamidis WC) is an official document issued by a regulatory agency to a Tafamidis manufacturer, verifying that the manufacturing facility of a Tafamidis active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tafamidis APIs or Tafamidis finished pharmaceutical products to another nation, regulatory agencies frequently require a Tafamidis WC (written confirmation) as part of the regulatory process.
click here to find a list of Tafamidis suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tafamidis as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tafamidis API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tafamidis as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tafamidis and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tafamidis NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tafamidis suppliers with NDC on PharmaCompass.
Tafamidis Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tafamidis GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tafamidis GMP manufacturer or Tafamidis GMP API supplier for your needs.
A Tafamidis CoA (Certificate of Analysis) is a formal document that attests to Tafamidis's compliance with Tafamidis specifications and serves as a tool for batch-level quality control.
Tafamidis CoA mostly includes findings from lab analyses of a specific batch. For each Tafamidis CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tafamidis may be tested according to a variety of international standards, such as European Pharmacopoeia (Tafamidis EP), Tafamidis JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tafamidis USP).
Market Place
